Met Life Investment Management, LLC Humacyte, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 44,960 shares of HUMA stock, worth $75,532. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,960
Previous 52,295
14.03%
Holding current value
$75,532
Previous $284,000
20.07%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding HUMA
# of Institutions
170Shares Held
40.8MCall Options Held
553KPut Options Held
942K-
Black Rock Inc. New York, NY7.14MShares$12 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$9.41 Million0.0% of portfolio
-
State Street Corp Boston, MA4.61MShares$7.75 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA2.85MShares$4.79 Million0.11% of portfolio
-
Geode Capital Management, LLC Boston, MA2.14MShares$3.59 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $173M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...